Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07088055 · ClinicalTrials.gov registry record · NA
Trial to Compare the Effects of Myo Munchee Therapy and Oral Motor Therapy (OMT) in Pediatric Patients to Treat Maxillary Deficiency and Orofacial Myofunctional Dysfunction (OMD).
A NA study of Orofacial Myofunctional Disorders and Myo Munchee, sponsored by Myo Munchee (Operations) Pty.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 2
- Study locations
NCT07088055: Recruiting NA study of Orofacial Myofunctional Disorders and Myo Munchee, sponsored by Myo Munchee (Operations) Pty.
NCT07088055 is a NA study of Orofacial Myofunctional Disorders and Myo Munchee that is actively recruiting participants, run by Myo Munchee (Operations) Pty. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07088055, a NA study of Orofacial Myofunctional Disorders and Myo Munchee, is actively recruiting participants, sponsored by Myo Munchee (Operations) Pty.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 2
- Study locations
Study Summary
Multi-center, 6-month, randomized, and controlled trial to compare the effects of Myo Munchee therapy and Oral Motor Therapy (OMT) in pediatric patients (aged 3-5 years) to treat maxillary deficiency and orofacial myofunctional dysfunction (OMD).
Primary Outcome
1. Palatal transverse width (in mm) expansion. Measured using an intraoral 3D iTero scanner. 2. Palatal sagittal depth (in mm) expansion. Measured using an intraoral 3D iTero scanner. 3. Palatal vault height (in mm) expansion. Intraoral measurements taken using an intraoral 3D iTero scanner, which is used to print a 3D model of the intraoral maxilla. The palatal height will then be measured using a GPM \& Holtain Palatometer (Model no. 215)
Conditions Studied
Interventions
- DEVICE Chewing device only
- DEVICE Myo Munchee and Oral Motor Therapy Treatment
- OTHER Oral Motor Therapy Treatment Arm
Study Locations (2)
Illinois
- Center for Svedhyaya Therapy Services - Chicago
- Dentistry for Children - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2025-08-20 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT07088055 shows while recruiting
NCT07088055 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Orofacial Myofunctional Disorders appearing as the primary indexed condition, and to 3 interventions - of which Chewing device only is the first listed.
NCT07088055 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07088055 about?
NCT07088055 is a clinical study titled "Trial to Compare the Effects of Myo Munchee Therapy and Oral Motor Therapy (OMT) in Pediatric Patients to Treat Maxillary Deficiency and Orofacial Myofunctional Dysfunction (OMD).". Multi-center, 6-month, randomized, and controlled trial to compare the effects of Myo Munchee therapy and Oral Motor Therapy (OMT) in pediatric patients (aged 3-5 years) to treat maxillary deficiency and orofacial myofunctional dysfunction (OMD).
What is the current status of trial NCT07088055?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2025-08-20. Estimated completion is 2027-06.
What conditions does trial NCT07088055 study?
This clinical trial studies the following conditions: Orofacial Myofunctional Disorders, Myo Munchee, Oral Motor Therapy, Maxillary Deficiency.
What interventions are being tested in trial NCT07088055?
The interventions under investigation include: Chewing device only (DEVICE), Myo Munchee and Oral Motor Therapy Treatment (DEVICE), Oral Motor Therapy Treatment Arm (OTHER).
Who is sponsoring clinical trial NCT07088055?
This trial is sponsored by Myo Munchee (Operations) Pty, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07088055 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07088055's enrollment target sits among peer trials
48 1382nd of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI